Angiotensin-Converting Enzyme Inhibitor Angiotensin II Receptor Blocker in COVID-19: A Double-Edged Sword or a Myth. Nep. Med. J. 2020, 3 (1), 309-312. https://doi.org/10.3126/nmj.v3i1.28726.